Lowest Price Guaranteed
Pages
197
Last Updated
April 2026
View Count
16081
Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the current state of biopreservation media providers market and its likely evolution in the short-mid and long term.
Chapter 3 provides a general overview of biopreservation. It also features the type of biopreservation, including hypothermic preservation and cryopreservation along with the details of hypothermic biopreservation media and cryopreservation media. Additionally, it highlights details regarding applications of biopreservation media, as well as various benefits and limitations associated with the use of such media.
Chapter 4 includes a detailed analysis of the current service providers landscape of biopreservation media providers, including information on the year of establishment, company size, type of company and location of headquarters. In addition, it presents the current market landscape of biopreservation media based on several relevant parameters, such as preservation condition, type of serum, type of biological sample, area of application, type of packaging format, packaging volume and product price.
Chapter 5 features an in-depth analysis of the contemporary trends, highlighted through various schematic representations, including a world map representation highlighting the location of biopreservation media providers, a 4D bubble chart based on the year of establishment, company size, number of biopreservation media offered and region, an insightful treemap representation based on preservation condition and area of application, a grid representation based on company size, region, preservation condition, type of serum and type of biological sample, and a heat map representation based on minimum packaging volume and minimum price.
Chapter 6 presents an in-depth company competitiveness analysis of biopreservation media providers, taking into consideration various relevant parameters, such as years of experience, product portfolio strength (in terms of preservation condition presence of serum, type of biological sample, maximum packaging volume, and area of application), and partnership activity (in terms of number of partnerships and type of agreements).
Chapter 7 features detailed profiles of various prominent players that are engaged in providing biopreservation media. Each company profile features a brief overview of the company (including information on its year of establishment, number of employees, location of headquarters and key members of the executive team), recent developments and an informed future outlook.
Chapter 8 features an analysis of the partnerships that have been inked between several stakeholders in this domain, since 2015. Additionally, It includes a brief description of various partnership models (namely manufacturing and supply agreements, product distribution agreements, product development agreements, acquisitions and other agreements).Further, it includes a detailed analysis of partnerships, based on the year of partnership, type of partnership, location of headquarters of partner and other relevant parameters.
Chapter 9 presents a Bowman’s strategy clock framework in order to understand the pricing strategy of the biopreservation media offered by the company along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the biopreservation media based upon its characteristics.
Chapter 10 presents an insightful market forecast analysis, highlighting the likely growth of biopreservation media market till 2035. We have segmented the market across preservation condition (cryogenic / LN2 vapor phase, frozen (ultra-low) / deep frozen, frozen / cold chain, and refrigerated), type of serum (fetal bovine serum containing media, fetal calf serum containing media, human serum containing media, and serum free media), type of biological sample (germline cells / stem cells, organs, somatic cells, and tissues), area of application (diagnostic use, research and development, and therapeutic use), type of packaging format (bags, bottles, vials, and others), end users (academic and research institutes, biobanks / genebanks, hospitals, pharmaceutical and biotechnology companies, and other end users), and region (North America, Europe, Asia, MENA, Latin America, and Rest of the World).
Chapter 11 summarizes the overall report, wherein we have mentioned all the key facts and figures described in the previous chapters. The chapter also highlights important evolutionary trends that were identified during the course of the study and are expected to influence the future of the biopreservation media provider’s market.
Chapter 12 presents the interview transcript of discussion held with the stakeholder in this market. The chapter provides a brief overview of the company and details of interview held with Robert Gobern (Marketing Director, Cytes Biotechnologies).
Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.
Chapter 14 is an appendix, which contains the list of companies and organizations mentioned in the report.
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
2.1. Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Biopreservation
3.3. Type of Biopreservation
3.3.1. Hypothermic Preservation
3.3.2. Cryopreservation
3.4. Applications of Biopreservation Media
3.5. Benefits and Limitations of Biopreservation Media
3.6. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Biopreservation Media Providers: Service Providers Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Type of Company
4.2.4. Analysis by Location of Headquarters
4.3. Biopreservation Media: Market Landscape
4.3.1. Analysis by Preservation Condition
4.3.2. Analysis by Type of Serum
4.3.3. Analysis by Type of Biological Sample
4.3.4. Analysis by Area of Application
4.3.5. Analysis by Type of Packaging Format
4.3.6. Analysis by Packaging Volume
4.3.7. Analysis by Product Price
5. KEY INSIGHTS
5.1. Chapter Overview
5.2. Analysis by Location of Headquarters (World Map Representation)
5.3. Analysis by Year of Establishment, Company Size, Number of Biopreservation Media
Offered and Region (4D Bubble Chart)
5.4. Analysis by Preservation Condition and Area of Application (Treemap Representation)
5.5. Analysis by Company Size, Region, Preservation Condition, Type of Serum and Type of Biological Sample (Grid Representation)
5.6. Analysis by Minimum Packaging Volume and Minimum Price (Heat Map Representation)
6. COMPANY COMPETITIVENESS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Benchmarking of Product Portfolio Strength
6.5. Benchmarking of Partnership Activity
6.6. Biopreservation Media Providers: Company Competitiveness Analysis
6.6.1. Company Competitiveness Analysis: Very Small Companies
6.6.2. Company Competitiveness Analysis: Small Companies
6.6.3. Company Competitiveness Analysis: Mid-Sized Companies
6.6.4. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. BioLife Solutions
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook
7.3. Cell Applications
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook
7.4. HiMedia Laboratories
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook
7.5. Merck
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook
7.6. Thermo Fischer Scientific
7.6.1. Company Overview
7.6.2. Recent Developments and Future Outlook
7.7. United States Biological
7.7.1. Company Overview
7.7.2. Recent Developments and Future Outlook
7.8. ZenBio
7.8.1. Company Overview
7.8.2. Recent Developments and Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Biopreservation Media Providers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.2.1. Analysis by Year and Type of Partnership
8.3.2.2. Analysis by Type of Partnership and Company Size
8.3.3. Analysis by Type of Partner
8.3.3.1. Analysis by Year of Partnership and Type of Partner
8.3.3.2. Analysis by Type of Partner and Type of Partnership
8.3.3.3. Analysis by Type of Partner and Company Size
8.3.4. Most Active Players: Analysis by Number of Partnerships
8.3.5. Regional Analysis
8.3.5.1. Local and International Deals
8.3.5.2. Intercontinental and Intracontinental Deals
8.3.5.3. Analysis by Location of Headquarters of Partner
8.3.5.4. Analysis by Location of Headquarters of Partner and Type of Partnership
9. BOWMAN CLOCK PRICING STRATEGY
9.1. Chapter Overview
9.2. Bowman Strategy Clock
9.2.1. Two Dimensions of Bowman Strategy Clock
9.2.2. Eight Positions on Bowman Strategy Clock
9.3. Roots Analysis Framework
9.3.1. Methodology
9.3.2. Theoretical Framework and Price Evaluation Hypothesis
9.3.3. Results and Interpretation
9.3.3.1. Product Price Evaluation Matrix: Information on Preservation Condition
9.3.3.2. Product Price Evaluation Matrix: Information on Type of Serum
9.3.3.3. Product Price Evaluation Matrix: Information on Type of Biological Sample
9.3.3.4. Product Price Evaluation Matrix: Information on Minimum Packaging Volume
9.3.3.5. Product Price Evaluation Matrix: Information on Maximum Packaging Volume
9.3.3.6. Product Price Evaluation Matrix: Information on Packaging Format
9.3.3.7. Product Price Evaluation Matrix: Information on Area of Application
9.3.4. Concluding Remarks
10. MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Biopreservation Media Providers Market, 2021-2035
10.4. Biopreservation Media Providers Market: Distribution by Preservation Condition, 2021 and 2035
10.4.1. Biopreservation Media Providers Market for Cryogenic / LN2 Vapor Phase, 2021-2035
10.4.2. Biopreservation Media Providers Market for Frozen (Ultra-low) / Deep Frozen, 2021-2035
10.4.3. Biopreservation Media Providers Market for Frozen / Cold Chain, 2021-2035
10.4.4. Biopreservation Media Providers Market for Refrigerated, 2021-2035
10.5. Biopreservation Media Providers Market: Distribution by Type of Serum, 2021 and 2035
10.5.1. Biopreservation Media Providers Market for Fetal Bovine Serum Containing Media, 2021-2035
10.5.2. Biopreservation Media Providers Market for Fetal Calf Serum Containing Media, 2021-2035
10.5.3. Biopreservation Media Providers Market for Human Serum Containing Media, 2021-2035
10.5.4. Biopreservation Media Providers Market for Serum Free Media, 2021-2035
10.6. Biopreservation Media Providers Market: Distribution by Type of Biological Sample, 2021 and 2035
10.6.1. Biopreservation Media Providers Market for Germline Cells / Stem Cells, 2021-2035
10.6.2. Biopreservation Media Providers Market for Organs, 2021-2035
10.6.3. Biopreservation Media Providers Market for Somatic Cells, 2021-2035
10.6.4. Biopreservation Media Providers Market for Tissues, 2021-2035
10.7. Biopreservation Media Providers Market: Distribution by Area of Application, 2021 and 2035
10.7.1. Biopreservation Media Providers Market for Diagnostic Use, 2021-2035
10.7.2. Biopreservation Media Providers Market for Research and Development, 2021-2035
10.7.3. Biopreservation Media Providers Market for Therapeutic Use, 2021-2035
10.8. Biopreservation Media Providers Market: Distribution by Type of Packaging Format, 2021 and 2035
10.8.1. Biopreservation Media Providers Market for Bags, 2021-2035
10.8.2. Biopreservation Media Providers Market for Bottles, 2021-2035
10.8.3. Biopreservation Media Providers Market for Vials, 2021-2035
10.8.4. Biopreservation Media Providers Market for Others, 2021-2035
10.9. Biopreservation Media Providers Market: Distribution by End Users, 2021 and 2035
10.9.1. Biopreservation Media Providers Market for Academic and Research Institutes, 2021-2035
10.9.2. Biopreservation Media Providers Market for Biobanks / Genebanks, 2021-2035
10.9.3. Biopreservation Media Providers Market for Hospitals, 2021-2035
10.9.4. Biopreservation Media Providers Market for Pharmaceutical and Biotechnology Companies, 2021-2035
10.9.5. Biopreservation Media Providers Market for Other End Users, 2021-2035
10.10. Biopreservation Media Providers Market: Distribution by Region, 2021 and 2035
10.10.1. Biopreservation Media Providers Market in North America, 2021-2035
10.10.2. Biopreservation Media Providers Market in Europe, 2021-2035
10.10.3. Biopreservation Media Providers Market in Asia, 2021-2035
10.10.4. Biopreservation Media Providers Market in MENA, 2021-2035
10.10.5. Biopreservation Media Providers Market in Latin America, 2021-2035
10.10.6. Biopreservation Media Providers Market in Rest of the World, 2021-2035
10.11. Concluding Remarks
11. CONCLUSION
11.1. Chapter Overview
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Cytes Biotechnologies
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Robert Gobern, Marketing Director
13. APPENDIX I: TABULATED DATA
14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION
Figure 2.1 Executive Summary: Service Providers Landscape
Figure 2.2 Executive Summary: Market Landscape
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Current and Future Market Potential
Figure 3.1 Applications of Biopreservation Media
Figure 3.2 Key Benefits and Limitations of Hypothermic Biopreservation Media
Figure 3.3 Key Benefits and Limitations of Cryopreservation Media
Figure 4.1 Biopreservation Media Providers: Distribution by Year of Establishment
Figure 4.2 Biopreservation Media Providers: Distribution by Company Size
Figure 4.3 Biopreservation Media Providers: Distribution by Type of Company
Figure 4.4 Biopreservation Media Providers: Distribution by Location of Headquarters
Figure 4.5 Biopreservation Media: Distribution by Preservation Condition
Figure 4.6 Biopreservation Media: Distribution by Type of Serum
Figure 4.7 Biopreservation Media: Distribution by Type of Biological Sample
Figure 4.8 Biopreservation Media: Distribution by Area of Application
Figure 4.9 Biopreservation Media: Distribution by Type of Packaging Format
Figure 4.10 Biopreservation Media: Distribution by Minimum Packaging Volume (mL)
Figure 4.11 Biopreservation Media: Distribution by Maximum Packaging Volume (mL)
Figure 4.12 Biopreservation Media: Distribution by Minimum Price (USD)
Figure 4.13 Biopreservation Media: Distribution by Maximum Price (USD)
Figure 5.1 Biopreservation Media Providers: Distribution by Location of Headquarters (World Map Representation)
Figure 5.2 Biopreservation Media Providers: Distribution by Year of Establishment, Company Size, Number of Biopreservation Media Offered and Region (4D Bubble Chart)
Figure 5.3 Biopreservation Media: Distribution by Preservation Condition and Area of Application (Treemap Representation)
Figure 5.4 Biopreservation Media: Distribution by Company Size, Region, Preservation Condition, Type of Serum and Type of Biological Sample (Grid Representation)
Figure 5.5 Biopreservation Media: Distribution by Minimum Packaging Volume and Minimum Price (Heat Map Representation)
Figure 6.1 Company Competitiveness Analysis: Benchmarking of Product Portfolio Strength
Figure 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Figure 6.3 Company Competitiveness Analysis: Very Small Companies
Figure 6.4 Company Competitiveness Analysis: Small Companies
Figure 6.5 Company Competitiveness Analysis: Mid-Sized Companies
Figure 6.6 Company Competitiveness Analysis: Large Companies
Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2021
Figure 8.2 Partnerships and Collaborations: Logo Landscape
Figure 8.3 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Partner
Figure 8.7 Partnerships and Collaborations: Year-wise Distribution by Type of Partner
Figure 8.8 Partnerships and Collaborations: Distribution by Type of Partner and Type of Partnership
Figure 8.9 Partnerships and Collaborations: Distribution by Type of Partner and Company Size
Figure 8.10 Partnerships and Collaborations: Distribution by Number of Partnerships
Figure 8.11 Partnerships and Collaborations: Local and International Deals
Figure 8.12 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 8.13 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Figure 8.14 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner and Type of Partnership
Figure 9.1 Biopreservation Media: Bowman Clock Pricing Strategy Matrix
Figure 9.2 Biopreservation Media: Bowman Clock Pricing Strategy Graphical Interpretation
Figure 10.1 Biopreservation Media Providers Market, 2021-2035 (USD Million)
Figure 10.2 Biopreservation Media Providers Market: Distribution by Preservation Condition, 2021 and 2035
Figure 10.3 Biopreservation Media Providers Market for Cryogenic / LN2 Vapor Phase, 2021-2035 (USD Million)
Figure 10.4 Biopreservation Media Providers Market for Frozen (Ultra-low) / Deep Frozen, 2021-2035 (USD Million)
Figure 10.5 Biopreservation Media Providers Market for Frozen / Cold Chain, 2021-2035 (USD Million)
Figure 10.6 Biopreservation Media Providers Market for Refrigerated, 2021-2035 (USD Million)
Figure 10.7 Biopreservation Media Providers Market: Distribution by Type of Serum, 2021 and 2035
Figure 10.8 Biopreservation Media Providers Market for Fetal Bovine Serum Containing Media, 2021-2035 (USD Million)
Figure 10.9 Biopreservation Media Providers Market for Fetal Calf Serum Containing Media, 2021-2035 (USD Million)
Figure 10.10 Biopreservation Media Providers Market for Human Serum Containing Media, 2021-2035 (USD Million)
Figure 10.11 Biopreservation Media Providers Market for Serum Free Media, 2021-2035 (USD Million)
Figure 10.12 Biopreservation Media Providers Market: Distribution by Type of Biological Sample, 2021 and 2035
Figure 10.13 Biopreservation Media Providers Market for Germline Cells / Stem Cells, 2021-2035 (USD Million)
Figure 10.14 Biopreservation Media Providers Market for Organs, 2021-2035 (USD Million)
Figure 10.15 Biopreservation Media Providers Market for Somatic Cells, 2021-2035 (USD Million)
Figure 10.16 Biopreservation Media Providers Market for Tissues, 2021-2035 (USD Million)
Figure 10.17 Biopreservation Media Providers Market: Distribution by Area of Application, 2021 and 2035
Figure 10.18 Biopreservation Media Providers Market for Diagnostic Use, 2021-2035 (USD Million)
Figure 10.19 Biopreservation Media Providers Market for Research and Development, 2021-2035 (USD Million)
Figure 10.20 Biopreservation Media Providers Market for Therapeutic Use, 2021-2035 (USD Million)
Figure 10.21 Biopreservation Media Providers Market: Distribution by Type of Packaging Format, 2021 and 2035
Figure 10.22 Biopreservation Media Providers Market for Bags, 2021-2035 (USD Million)
Figure 10.23 Biopreservation Media Providers Market for Bottles, 2021-2035 (USD Million)
Figure 10.24 Biopreservation Media Providers Market for Vials, 2021-2035 (USD Million)
Figure 10.25 Biopreservation Media Providers Market for Others, 2021-2035 (USD Million)
Figure 10.26 Biopreservation Media Providers Market: Distribution by End Users, 2021 and 2035
Figure 10.27 Biopreservation Media Providers Market for Academic and Research Institutes, 2021-2035 (USD Million)
Figure 10.28 Biopreservation Media Providers Market for Biobanks / Genebanks, 2021-2035 (USD Million)
Figure 10.29 Biopreservation Media Providers Market for Hospitals, 2021-2035 (USD Million)
Figure 10.30 Biopreservation Media Providers Market for Pharmaceutical and Biotechnology Companies, 2021-2035 (USD Million)
Figure 10.31 Biopreservation Media Providers Market for Other End Users, 2021-2035 (USD Million)
Figure 10.32 Biopreservation Media Providers Market: Distribution by Region, 2021 and 2035
Figure 10.33 Biopreservation Media Providers Market in North America, 2021-2035 (USD Million)
Figure 10.34 Biopreservation Media Providers Market in Europe, 2021-2035 (USD Million)
Figure 10.35 Biopreservation Media Providers Market in Asia, 2021-2035 (USD Million)
Figure 10.36 Biopreservation Media Providers Market in MENA, 2021-2035 (USD Million)
Figure 10.37 Biopreservation Media Providers Market in Latin America, 2021-2035 (USD Million)
Figure 10.38 Biopreservation Media Providers Market in Rest of the World, 2021-2035 (USD Million)
Figure 10.39 Biopreservation Media Providers Market, Conservative, Base and Optimistic Scenarios, 2021, 2028 and 2035 (USD Million)
Figure 11.1 Concluding Remarks: Current Market Landscape
Figure 11.2 Concluding Remarks: Company Competitiveness Analysis
Figure 11.3 Concluding Remarks: Partnerships and Collaborations
Figure 11.4 Concluding Remarks: Market Sizing and Opportunity Analysis
Table 4.1 Biopreservation Media Providers: Information on Year of Establishment, Company Size, Location of Headquarters (Country-wise and Region-wise) and Company Type
Table 4.2 Biopreservation Media: Information on Preservation Condition
Table 4.3 Biopreservation Media: Information on Type of Serum
Table 4.4 Biopreservation Media: Information on Type of Biological Sample
Table 4.5 Biopreservation Media: Information on Area of Application
Table 4.6 Biopreservation Media: Information on Type of Packaging Format
Table 4.7 Biopreservation Media: Information on Packaging Volume and Product Price
Table 6.1 Company Competitiveness Analysis: Benchmarking of Product Portfolio Strength
Table 6.2 Company Competitiveness Analysis: Benchmarking of Partnership Activity
Table 6.3 Company Competitiveness Analysis: List of Very Small Players
Table 6.4 Company Competitiveness Analysis: List of Small Players
Table 6.5 Company Competitiveness Analysis: List of Mid-Sized Players
Table 6.6 Company Competitiveness Analysis: List of Large Players
Table 7.1 List of Companies Profiled
Table 7.2 BioLife Solutions: Company Overview
Table 7.3 BioLife Solutions: Recent Developments and Future Outlook
Table 7.4 Cell Applications: Company Overview
Table 7.5 HiMedia Laboratories: Company Overview
Table 7.6 HiMedia Laboratories: Recent Developments and Future Outlook
Table 7.7 Merck: Company Overview
Table 7.8 Merck: Recent Developments and Future Outlook
Table 7.9 Thermo Fischer Scientific: Company Overview
Table 7.10 Thermo Fischer Scientific: Recent Developments and Future Outlook
Table 7.11 United States Biological: Company Overview
Table 7.12 ZenBio: Company Overview
Table 7.13 ZenBio: Recent Developments and Future Outlook
Table 8.1 Biopreservation Media: List of Collaborations, 2015-2021
Table 8.2 Biopreservation Media Providers: Partnerships and Collaborations, Information on Type of Agreement (Local and International Deals) and (Intercontinental and Intracontinental Deals), 2015-2021
Table 9.1 Product Price Evaluation Matrix: Information on Preservation Condition (USD)
Table 9.2 Product Price Evaluation Matrix: Information on Type of Serum (USD)
Table 9.3 Product Price Evaluation Matrix: Information on Type of Biological Sample (USD)
Table 9.4 Product Price Evaluation Matrix: Information on Minimum Packaging Volume (USD)
Table 9.5 Product Price Evaluation Matrix: Information on Maximum Packaging Volume (USD)
Table 9.6 Product Price Evaluation Matrix: Information on Packaging Format (USD)
Table 9.7 Product Price Evaluation Matrix: Information on Area of Application (USD)
Table 12.1 Cytes Biotechnologies: Company Snapshot
Table 13.1 Biopreservation Media Providers: Distribution by Year of Establishment
Table 13.2 Biopreservation Media Providers: Distribution by Company Size
Table 13.3 Biopreservation Media Providers: Distribution by Type of Company
Table 13.4 Biopreservation Media Providers: Distribution by Location of Headquarters
Table 13.5 Biopreservation Media: Distribution by Preservation Condition
Table 13.6 Biopreservation Media: Distribution by Type of Serum
Table 13.7 Biopreservation Media: Distribution by Type of Biological Sample
Table 13.8 Biopreservation Media: Distribution by Area of Application
Table 13.9 Biopreservation Media: Distribution by Type of Packaging Format
Table 13.10 Biopreservation Media: Distribution by Minimum Packaging Volume (mL)
Table 13.11 Biopreservation Media: Distribution by Maximum Packaging Volume (mL)
Table 13.12 Biopreservation Media: Distribution by Minimum Price (USD)
Table 13.13 Biopreservation Media: Distribution by Maximum Price (USD)
Table 13.14 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2021
Table 13.15 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.16 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.17 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 13.18 Partnerships and Collaborations: Distribution by Type of Partner
Table 13.19 Partnerships and Collaborations: Year-wise Distribution by Type of Partner
Table 13.20 Partnerships and Collaborations: Distribution by Type of Partner and Type of Partnership
Table 13.21 Partnerships and Collaborations: Distribution by Type of Partner and Company Size
Table 13.22 Partnerships and Collaborations: Distribution by Number of Partnerships
Table 13.23 Partnerships and Collaborations: Local and International Deals
Table 13.24 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Table 13.25 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner
Table 13.26 Partnerships and Collaborations: Distribution by Location of Headquarters of Partner and Type of Partnership
Table 13.27 Biopreservation Media Providers Market, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.28 Biopreservation Media Providers Market: Distribution by Preservation Condition, 2021 and 2035
Table 13.29 Biopreservation Media Providers Market for Cryogenic / LN2 Vapor Phase, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.30 Biopreservation Media Providers Market for Frozen (Ultra-low) / Deep Frozen, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.31 Biopreservation Media Providers Market for Frozen / Cold Chain, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.32 Biopreservation Media Providers Market for Refrigerated, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.33 Biopreservation Media Providers Market: Distribution by Type of Serum, 2021 and 2035
Table 13.34 Biopreservation Media Providers Market for Fetal Bovine Serum Containing Media, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.35 Biopreservation Media Providers Market for Fetal Calf Serum Containing Media, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.36 Biopreservation Media Providers Market for Human Serum Containing Media, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.37 Biopreservation Media Providers Market for Serum Free Media, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.38 Biopreservation Media Providers Market: Distribution by Type of Biological Sample, 2021 and 2035
Table 13.39 Biopreservation Media Providers Market for Germline Cells / Stem Cells, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.40 Biopreservation Media Providers Market for Organs, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.41 Biopreservation Media Providers Market for Somatic Cells, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.42 Biopreservation Media Providers Market for Tissues, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.43 Biopreservation Media Providers Market: Distribution by Area of Application, 2021 and 2035
Table 13.44 Biopreservation Media Providers Market for Diagnostic Use, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.45 Biopreservation Media Providers Market for Research and Development, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.46 Biopreservation Media Providers Market for Therapeutic Use, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.47 Biopreservation Media Providers Market: Distribution by Type of Packaging Format, 2021 and 2035
Table 13.48 Biopreservation Media Providers Market for Bags, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.49 Biopreservation Media Providers Market for Bottles, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.50 Biopreservation Media Providers Market for Vials, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.51 Biopreservation Media Providers Market for Others, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.52 Biopreservation Media Providers Market: Distribution by End Users, 2021 and 2035
Table 13.53 Biopreservation Media Providers Market for Academic and Research Institutes, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.54 Biopreservation Media Providers Market for Biobanks / Genebanks, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.55 Biopreservation Media Providers Market for Hospitals, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.56 Biopreservation Media Providers Market for Pharmaceutical and Biotechnology Companies, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.57 Biopreservation Media Providers Market for Other End Users, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.58 Biopreservation Media Providers Market: Distribution by Region, 2021 and 2035
Table 13.59 Biopreservation Media Providers Market in North America, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.60 Biopreservation Media Providers Market in Europe, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.61 Biopreservation Media Providers Market in Asia, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.62 Biopreservation Media Providers Market in MENA, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.63 Biopreservation Media Providers Market in Latin America, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.64 Biopreservation Media Providers Market in Rest of the World, 2021-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Please reach out to our team for the details.